UPDATE: Allergan (AGN) Said in Advanced Talks to Buy U.K.'s Kandy - Bloomberg

January 25, 2018 7:42 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Updated - January 25, 2018 7:44 AM EST)

Allergan (NYSE: AGN) is in advanced talks to acquire U.K.'s Kandy Therapeutics, according to Bloomberg, citing people with knowlege of the matter. Kandy could be valued at more than $400 million based on upfront and milestone payments.

An agreement could be reached soon, but other suitors may still emerge.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors

Related Entities

Definitive Agreement